The Medical Letter on Drugs and Therapeutics
FROM
ISSUE 903
ISSUE 903
August 20, 1993
Issue 903
Subscribers: Log in to read full issue. Not a subscriber? Subscribe or purchase issue.
Enoxaparin - A Low-Molecular-Weight Heparin
August 20, 1993 (Issue: 903)
Enoxaparin (Lovenox - Rh ne-Poulenc Rorer), the first low-molecular-weight heparin to become commercially available in the USA, was recently approved by the US Food and Drug Administration for prevention of deep vein thrombosis following hip...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.